By Karlee Weinmann ( July 30, 2013, 3:45 PM EDT) -- Alexion Pharmaceuticals Inc. has tapped Goldman Sachs Group Inc. as an adviser after speculation began to swirl that rival Roche Holding AG is plotting a takeover, Bloomberg reported on Tuesday. Roche last week preliminarily approached Alexion, whose blood disease medication clocks in among the most expensive treatments in the world, but the Connecticut-based company rebuffed the interest. But Alexion wants Goldman on its side if Roche ups its bid or shifts its focus to a hostile pursuit. Alexion, whose shares surged on the news, has a market value of more than $20 billion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.